208 related articles for article (PubMed ID: 15215080)
1. Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs.
Dumitru R; Hornby JM; Nickerson KW
Antimicrob Agents Chemother; 2004 Jul; 48(7):2350-4. PubMed ID: 15215080
[TBL] [Abstract][Full Text] [Related]
2. The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2.
Chen S; Xia J; Li C; Zuo L; Wei X
BMC Microbiol; 2018 Dec; 18(1):203. PubMed ID: 30509171
[TBL] [Abstract][Full Text] [Related]
3. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
4. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
[TBL] [Abstract][Full Text] [Related]
5. Effects of tyrosol and farnesol on Candida albicans biofilm.
Sebaa S; Boucherit-Otmani Z; Courtois P
Mol Med Rep; 2019 Apr; 19(4):3201-3209. PubMed ID: 30816484
[TBL] [Abstract][Full Text] [Related]
6. Role for cell density in antifungal drug resistance in Candida albicans biofilms.
Perumal P; Mekala S; Chaffin WL
Antimicrob Agents Chemother; 2007 Jul; 51(7):2454-63. PubMed ID: 17502416
[TBL] [Abstract][Full Text] [Related]
7. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
De Brucker K; De Cremer K; Cammue BP; Thevissen K
Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
[TBL] [Abstract][Full Text] [Related]
8. In vitro method to study antifungal perfusion in Candida biofilms.
Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
[TBL] [Abstract][Full Text] [Related]
9. Antifungal drug susceptibility of oral Candida albicans isolates may be associated with apoptotic responses to Amphotericin B.
Yang C; Gong W; Lu J; Zhu X; Qi Q
J Oral Pathol Med; 2010 Feb; 39(2):182-7. PubMed ID: 19656268
[TBL] [Abstract][Full Text] [Related]
10. Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue.
Uppuluri P; Mekala S; Chaffin WL
Yeast; 2007 Aug; 24(8):681-93. PubMed ID: 17583896
[TBL] [Abstract][Full Text] [Related]
11. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.
Hornby JM; Jensen EC; Lisec AD; Tasto JJ; Jahnke B; Shoemaker R; Dussault P; Nickerson KW
Appl Environ Microbiol; 2001 Jul; 67(7):2982-92. PubMed ID: 11425711
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of a prenylated flavonoid from Dalea elegans against Candida albicans biofilms.
Peralta MA; da Silva MA; Ortega MG; Cabrera JL; Paraje MG
Phytomedicine; 2015 Oct; 22(11):975-80. PubMed ID: 26407939
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
[TBL] [Abstract][Full Text] [Related]
15. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
[TBL] [Abstract][Full Text] [Related]
16. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
17. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.
Shirazi F; Kontoyiannis DP
Virulence; 2015; 6(4):385-94. PubMed ID: 26065323
[TBL] [Abstract][Full Text] [Related]
18. Biofilm formation by and antifungal susceptibility of Candida isolates from urine.
Jain N; Kohli R; Cook E; Gialanella P; Chang T; Fries BC
Appl Environ Microbiol; 2007 Mar; 73(6):1697-703. PubMed ID: 17261524
[TBL] [Abstract][Full Text] [Related]
19. Enhanced production of farnesol by Candida albicans treated with four azoles.
Hornby JM; Nickerson KW
Antimicrob Agents Chemother; 2004 Jun; 48(6):2305-7. PubMed ID: 15155241
[TBL] [Abstract][Full Text] [Related]
20. A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.
Khot PD; Suci PA; Miller RL; Nelson RD; Tyler BJ
Antimicrob Agents Chemother; 2006 Nov; 50(11):3708-16. PubMed ID: 16966398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
